Are Eticovo and Hadlima the Same Thing?
Eticovo (etanercept-ykro) and Hadlima (adalimumab-bwwd) are tumor necrosis factor (TNF) blockers used to treat rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), and plaque psoriasis (Ps).
Hadlima is also used to treat adult Crohn's disease (CD) and ulcerative colitis (UC).
Hadlima is biosimilar to Humira (adalimumab) and Eticovo is biosimilar to Enbrel (etanercept).
Side effects of Eticovo that are different from Hadlima include diarrhea, itching, fever, and hives.
Side effects of Hadlima and Eticovo that are similar include infections (such as upper respiratory infections, nasopharyngitis, sinusitis, and influenza), injection site reactions (redness, itching, bleeding, pain, and swelling), and rash.
Side effects of Hadlima that are different from Eticovo include headache.
Both Hadlima and Eticovo may interact with abatacept, anakinra, and live vaccines.
Eticovo may also interact with cyclophosphamide and sulfasalazine.
Hadlima may also interact with warfarin, cyclosporine, and theophylline.
What Are Possible Side Effects of Eticovo?
Side effects of Eticovo include:
- infections (such as upper respiratory infections, nasopharyngitis, sinusitis, and influenza),
- injection site reactions,
- diarrhea,
- rash,
- itching,
- fever, and
- hives
What Are Possible Side Effects of Hadlima?
Common side effects of Hadlima include:
- infections (e.g. upper respiratory tract, sinusitis),
- injection site reactions (redness, itching, bleeding, pain, and swelling),
- headache, and
- rash
SLIDESHOW
What Is Rheumatoid Arthritis (RA)? Symptoms, Treatment, Diagnosis See SlideshowWhat Is Eticovo?
Eticovo (etanercept-ykro) is a tumor necrosis factor (TNF) blocker indicated for the treatment of rheumatoid arthritis (RA), polyarticular juvenile idiopathic arthritis (JIA) in patients aged 2 years or older, psoriatic arthritis (PsA), ankylosing spondylitis (AS), and plaque psoriasis (PsO) in patients 4 years or older. Eticovo is biosimilar to Enbrel (etanercept).
What Is Hadlima?
Hadlima (adalimumab-bwwd) is a tumor necrosis factor (TNF) blocker indicated for treatment of rheumatoid Arthritis (RA), juvenile idiopathic arthritis (JIA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), adult Crohn's disease (CD), ulcerative colitis (UC), and plaque psoriasis (Ps). Hadlima is biosimilar to Humira (adalimumab).
What Drugs Interact With Eticovo?
Eticovo may interact with "live vaccines," anakinra, abatacept, and cyclophosphamide, and sulfasalazine. Tell your doctor all medications and supplements you use and all vaccines you recently received. Tell your doctor if you are pregnant or plan to become pregnant before using Eticovo; it is unknown how it would affect a fetus. Eticovo passes into breast milk in low levels. Consult your doctor before breastfeeding.
What Drugs Interact With Hadlima?
Hadlima may interact with abatacept, anakinra, warfarin, cyclosporine, theophylline, and live vaccines.
QUESTION
The term arthritis refers to stiffness in the joints. See AnswerHow Should Eticovo Be Taken?
Eticovo is given by injection under the skin, in the stomach or thigh area, as directed by your doctor. Follow your doctor's directions and the schedule for your doses very carefully.
How Should Hadlima Be Taken?
The dose of Eticovo to treat adult rheumatoid arthritis and psoriatic arthritis is 50 mg once weekly with or without methotrexate (MTX). The dose of Eticovo to treat ankylosing spondylitis is 50 mg once weekly. The dose of Eticovo to treat adult plaque psoriasis is 50 mg twice weekly for 3 months, followed by 50 mg once weekly. The dose of Eticovo to treat pediatric plaque psoriasis or plaque psoriasis (patients who weigh 63 kg or more) is 50 mg once weekly.
From 
Rheumatoid Arthritis Resources
Featured Centers
Health Solutions From Our Sponsors
All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).
Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.
Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.
The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.
As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.
Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.
If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.
You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.
Samsung Bioepis. Eticovo Product Information.
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761066s000lbl.pdf
FDA. Hadlima Product Information.
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761059s000lbl.pdf